S. Langabeer, K. Haslam, M. Crampe, B. MacDonagh, and J. McHugh, “Suboptimal molecular response to tyrosine kinase inhibition associated with acquisition of a T240A ABL1 kinase domain mutation in a patient with chronic myeloid leukemia”, Exp. oncol., vol. 41, no. 1, pp. 82–83, Jun. 2023.